XinYue Equity
1
5M
1
1
- Areas of investment
Summary
Deals in the range of 5 - 10 millions dollars are the general things for fund. The important activity for fund was in 2016. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Cowin Capital, Anlongmed Fund. In the next rounds fund is usually obtained by Qiming Venture Partners, Northern Light Venture Capital, Cowin Capital.
Among the various public portfolio startups of the fund, we may underline Connect Biopharmaceuticals Among the most popular fund investment industries, there are Clinical Trials, Health Care. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Investments by industry
- Clinical Trials (1)
- Biotechnology (1)
- Therapeutics (1)
- Health Care (1)
- Medical (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2016
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Connect Biopharmaceuticals | 01 Nov 2016 | Biotechnology, Health Care, Medical, Therapeutics, Clinical Trials | Seed | 5M | China, Hebei, Tianjin |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.